CELLAAX is a clinical-stage biopharmaceutical company engaged in regenerative medicine. We are on the path of discovery, research, development and commercialisation of advanced cellular therapy. We are developing protocols and approaches in regenerative medicine that allows us to target diseases and help the human body heal, recover and repair itself from disease and injury within its natural capacity. Our methods have been proven to be effective – yielding desired outcomes and results. CELLAAX stem cells are ethically sourced, fulfilling all QA and QC stringent validation and adhering to international regulatory standards.